Literature DB >> 29948056

Society of Abdominal Radiology disease-focused panel on renal cell carcinoma: update on past, current, and future goals.

Matthew S Davenport1,2,3, Hersh Chandarana4, Nicole E Curci5, Ankur Doshi4, Samuel D Kaffenberger5, Ivan Pedrosa6, Erick M Remer7, Nicola Schieda8, Atul B Shinagare9, Andrew D Smith10, Zhen J Wang11, Shane A Wells12, Stuart G Silverman9.   

Abstract

The disease-focused panel (DFP) program was created by the Society of Abdominal Radiology (SAR) as a mechanism to "improve patient care, education, and research" in a "particular disease or a particular aspect of a disease". The DFP on renal cell carcinoma (RCC) was proposed in 2014 and has been functional for 4 years. Although nominally focused on RCC, the scope of the DFP has included indeterminate renal masses because many cannot be assigned a specific diagnosis when detected. Since its founding, the DFP has been active in a variety of clinical, research, and educational projects to optimize the care of patients with known or suspected RCC. The DFP is utilizing multi-institutional and cross-disciplinary collaboration to differentiate benign from malignant disease, optimize the management of early stage RCC, and ultimately to differentiate indolent from aggressive cancers. Several additional projects have worked to develop a quantitative biomarker that predicts metastatic RCC response to anti-angiogenic therapy. While disease focus is the premise by which all DFPs are created, it is likely that in the future the RCC DFP will need to expand or create new panels that will focus on other specific aspects of RCC-a result that the program's founders envisioned. New knowledge creates a need for more focus.

Entities:  

Keywords:  Disease-focused panel; Renal cancer; Renal cell carcinoma; Renal mass; Society of Abdominal Radiology

Mesh:

Substances:

Year:  2018        PMID: 29948056      PMCID: PMC6927035          DOI: 10.1007/s00261-018-1663-4

Source DB:  PubMed          Journal:  Abdom Radiol (NY)


  50 in total

1.  Interobserver variability in determining enhancement of renal masses on helical CT.

Authors:  C L Siegel; A J Fisher; H F Bennett
Journal:  AJR Am J Roentgenol       Date:  1999-05       Impact factor: 3.959

2.  Assessment of response to tyrosine kinase inhibitors in metastatic renal cell cancer: CT texture as a predictive biomarker.

Authors:  Vicky Goh; Balaji Ganeshan; Paul Nathan; Jaspal K Juttla; Anup Vinayan; Kenneth A Miles
Journal:  Radiology       Date:  2011-08-03       Impact factor: 11.105

3.  Prediction of growth rate of solid renal masses: utility of MR imaging features--preliminary experience.

Authors:  Katerina Dodelzon; Thais C Mussi; James S Babb; Samir S Taneja; Andrew B Rosenkrantz
Journal:  Radiology       Date:  2012-01-20       Impact factor: 11.105

4.  Delphi Method Validation of a Procedural Performance Checklist for Insertion of an Ultrasound-Guided Internal Jugular Central Line.

Authors:  Nicholas Hartman; Mary Wittler; Kim Askew; David Manthey
Journal:  Am J Med Qual       Date:  2014-09-10       Impact factor: 1.852

Review 5.  Diagnostic accuracy of segmental enhancement inversion for diagnosis of renal oncocytoma at biphasic contrast enhanced CT: systematic review.

Authors:  Nicola Schieda; Matthew D F McInnes; Lilly Cao
Journal:  Eur Radiol       Date:  2014-03-26       Impact factor: 5.315

6.  Pancreatic ductal adenocarcinoma radiology reporting template: consensus statement of the Society of Abdominal Radiology and the American Pancreatic Association.

Authors:  Mahmoud M Al-Hawary; Isaac R Francis; Suresh T Chari; Elliot K Fishman; David M Hough; David S Lu; Michael Macari; Alec J Megibow; Frank H Miller; Koenraad J Mortele; Nipun B Merchant; Rebecca M Minter; Eric P Tamm; Dushyant V Sahani; Diane M Simeone
Journal:  Radiology       Date:  2014-01       Impact factor: 11.105

7.  Differentiation of papillary renal cell carcinoma subtypes on CT and MRI.

Authors:  Nathan D Egbert; Elaine M Caoili; Richard H Cohan; Matthew S Davenport; Isaac R Francis; L Priya Kunju; James H Ellis
Journal:  AJR Am J Roentgenol       Date:  2013-08       Impact factor: 3.959

8.  Effect of Template Reporting of Brain MRIs for Multiple Sclerosis on Report Thoroughness and Neurologist-Rated Quality: Results of a Prospective Quality Improvement Project.

Authors:  Elliot Dickerson; Matthew S Davenport; Faiz Syed; Olaf Stuve; Jeffrey A Cohen; John R Rinker; Myla D Goldman; Benjamin M Segal; Bradley R Foerster
Journal:  J Am Coll Radiol       Date:  2016-12-05       Impact factor: 5.532

9.  Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization.

Authors:  Alan S Go; Glenn M Chertow; Dongjie Fan; Charles E McCulloch; Chi-yuan Hsu
Journal:  N Engl J Med       Date:  2004-09-23       Impact factor: 91.245

Review 10.  Percutaneous ablation for small renal masses-imaging follow-up.

Authors:  Jason D Iannuccilli; David J Grand; Damian E Dupuy; William W Mayo-Smith
Journal:  Semin Intervent Radiol       Date:  2014-03       Impact factor: 1.513

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.